v3.26.1
Equity-Accounted Investees and Joint Business - Breakdown of balances in joint arrangement (Details)
€ in Millions, $ in Millions
12 Months Ended
Dec. 31, 2025
EUR (€)
Dec. 31, 2025
USD ($)
Dec. 31, 2024
EUR (€)
Dec. 31, 2023
EUR (€)
Dec. 31, 2024
USD ($)
Dec. 31, 2022
EUR (€)
Equity-Accounted Investees and Joint Business            
Non-current assets € 14,638   € 15,677      
Current assets 5,074   5,728      
Total assets 19,712   21,405 € 20,992    
Non-current liabilities 10,090   10,643      
Current liabilities 2,019   2,156      
Total liabilities 12,109   12,799 13,479    
Equity-accounted investments 97   69 421   € 1,498
Total equity 7,603   8,606 [1] 7,513 [1]   € 7,977 [1]
Net revenue 7,524   7,212 6,592 [1]    
Consolidated net profit 500   213 € 163 [1]    
Biotek America LLC            
Equity-Accounted Investees and Joint Business            
Non-current assets     52   $ 54  
Current assets     26   27  
Total assets     78   81  
Non-current liabilities     54   56  
Current liabilities     45   47  
Total liabilities     99   103  
Equity-accounted investments     6   6  
Total equity     € (27)   $ (28)  
Net revenue 190 $ 206        
Consolidated net profit € 6 $ 6        
[1] (See Note 2.d)